Immunomedics News

News on Immunomedics (Ticker: IMMU) continually updated from thousands of sources around the net.

23 hrs ago | BioSpace

Immunomedics, Inc. to Present at Jefferies and Co. 2012 Global Healthcare Conference

MORRIS PLAINS, N.J., May 29, 2012 -- Immunomedics, Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that the Company will present at Jefferies 2012 Global Healthcare Conference at 1:30 p.m. on ... (more)

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Fri May 25, 2012

GlobeNewswire

Immunomedics to Present Final Results of Pancreatic Cancer Study With ...

MORRIS PLAINS, N.J., May 25, 2012 -- Immunomedics , Inc. , a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced that two presentations will be given at the 2012 Annual Meeting of the American Society of ... (more)

Comment?

Fri May 11, 2012

AmericanBankingNews.com

Immunomedics Incorporated's "Outperform" Rating Reaffirmed at Oppenheimer

's stock had its "outperform" rating reaffirmed by research analysts at Oppenheimer in a report released on Friday.

Comment?